NN3201
NCT06805825
Novelty Nobility · Phase 1 · Recruiting · Enrollment 67
| Arm | Population | Dose | Estimand | Comparator | Efficacy |
|---|
No efficacy figure is in this file for this study.
ACC
Programs, trials, and reported response and survival for adenoid cystic carcinoma.
NN3201
Novelty Nobility · Phase 1 · Recruiting · Enrollment 67
| Arm | Population | Dose | Estimand | Comparator | Efficacy |
|---|
No efficacy figure is in this file for this study.